PhaseⅡClinical Trial of Oral Hexavalent Reassortant Rotavirus Attenuated Live Vaccine (Vero Cells)

NCT06967272 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

400

Enrollment

INDUSTRY

Sponsor class

Conditions

Rotavirus Gastroenteritis

Interventions

BIOLOGICAL: Oral hexavalent reassortant rotavirus attenuated live vaccine
BIOLOGICAL: Oral hexavalent reassortant rotavirus attenuated live vaccine
BIOLOGICAL: Oral pentavalent reassortant rotavirus attenuated live vaccine (controlled)

Sponsor

Sinovac Life Sciences Co., Ltd.